Orphenadrine Extended-Release Tablets and Xpovio (100 MG Once Weekly)
Determining the interaction of Orphenadrine Extended-Release Tablets and Xpovio (100 MG Once Weekly) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
Generic Name: selinexor
Brand name: Xpovio
Synonyms: Xpovio
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Orphenadrine Extended-Release Tablets-Xpovio (60 MG Once Weekly)
- Orphenadrine Extended-Release Tablets-Xpovio (80 MG Once Weekly)
- Orphenadrine Extended-Release Tablets-Xpovio (80 MG Twice Weekly)
- Orphenadrine Extended-Release Tablets-Xryliderm
- Orphenadrine Extended-Release Tablets-Xrylix
- Orphenadrine Extended-Release Tablets-Xtampza ER
- Xpovio (100 MG Once Weekly)-Orphenadrine Injection
- Xpovio (100 MG Once Weekly)-Orphenadrine w/A.C.
- Xpovio (100 MG Once Weekly)-Orphenadrine, aspirin, and caffeine
- Xpovio (100 MG Once Weekly)-Orphenate
- Xpovio (100 MG Once Weekly)-Orphengesic
- Xpovio (100 MG Once Weekly)-Orphengesic Forte